Advertisement

Drugs & Aging

, Volume 28, Issue 12, pp 993–1005 | Cite as

Gender Disparities in the Pharmacological Treatment of Cardiovascular Disease and Diabetes Mellitus in the Very Old

An Epidemiological, Cross-Sectional Survey
  • Jon BrännströmEmail author
  • Katarina Hamberg
  • Lena Molander
  • Hugo Lövheim
  • Yngve Gustafson
Original Research Article

Abstract

Background: There are many reports of disparities in health and medical care both between women and men and between various age groups. In most cases, men receive better treatment than women and young and middle-aged people are privileged compared with the old and the very old. Cardiovascular morbidity and diabetes mellitus are common, increase with age and are often treated extensively with drugs, many of which are known to have significant adverse effects.

Objective: The aim of the study was to analyse gender differences in the pharmacological treatment of cardiovascular disease and diabetes among very old people.

Methods: The study took the form of an epidemiological, cross-sectional survey. A structured interview was administered during one or more home visits, and data were further retrieved from medical charts and interviews with relatives, healthcare staff and other carers. Home-dwelling people as well as people living in institutional care in six municipalities in the county of Västerbotten, Sweden, in 2005–7 were included in the study. Half of all people aged 85 years, all of those aged 90 years and all of those aged ≥95 years living in the selected municipalities were selected for inclusion in the study. In total, 467 people were included in the present analysis. The main study outcome measures were medical diagnoses and drug use.

Results: In total, women were prescribed a larger number of drugs than men (mean 7.2 vs 5.4, p<0.001). Multiple logistic regression models adjusted for age and other background variables as well as relevant medical diagnoses (hypertension, heart failure) showed strong associations between female sex and prescriptions of thiazide diuretics (odds ratio [OR] 4.4; 95% CI 1.8, 10.8; p = 0.001), potassium-sparing diuretics (OR 3.5; 95% CI 1.4, 8.7; p = 0.006) and diuretics as a whole (OR 1.8; 95% CI 1.1, 2.9; p = 0.021). A similar model, adjusted for angina pectoris, showed that female sex was associated with prescription of short-acting nitroglycerin (OR 3.7; 95% CI 1.6, 8.9; p = 0.003). However, more men had been offered coronary artery surgery (p = 0.001). Of the participants diagnosed with diabetes, 55% of the women and 85% of the men used oral antihyperglycaemic drugs (p = 0.020), whereas no gender difference was seen in prescriptions of insulin.

Conclusions: Significant gender disparities in the prescription of several drugs, such as diuretics, nitroglycerin and oral antihyperglycaemic drugs, were observed in this study of very old people. In most cases, women were prescribed more drugs than men. Men more often had undergone coronary artery surgery. These disparities could only in part be explained by differences in diagnoses and symptoms.

Keywords

Nitroglycerin Loop Diuretic Thiazide Diuretic Gender Disparity Civil Registration Number 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Acknowledgements

This study was supported by grants from the European Union Bothnia-Atlantica Program, the Vårdal Research Foundation, the King Gustav V’s and Queen Viktoria’s Foundation of Freemasons, the Umeå University Foundations for Medical Research, the Erik and Anne-Marie Detlof’s Foundation at Umeå University, the Swedish Dementia Association and Interreg IIIA Mitt-Skandia.

None of the funding sources had any financial interest in the study, and none of them were involved in the data collection or the analyses. The authors declare that they have no competing interests.

References

  1. 1.
    Swahn E. The care of patients with ischaemic heart disease from a gender perspective. Eur Heart J 1998; 19(12): 1758–65PubMedCrossRefGoogle Scholar
  2. 2.
    Thorslund M, Lennartsson C, Parker MG, et al. Health status of the oldest old has changed for the worse: big differences between the sexes. Health of the women is worse than health of the men as illuminated by new data. Lakartidningen 2004; 101(17): 1494–9Google Scholar
  3. 3.
    Kosiak B, Sangl J, Correa-de-Araujo R. Quality of health care for older women: what do we know? Womens Health Issues 2006; 16(2): 89–99PubMedCrossRefGoogle Scholar
  4. 4.
    Fremont AM, Correa-de-Araujo R, Hayes SN. Gender disparities in managed care: it’s time for action. Womens Health Issues 2007; 17(3): 116–9PubMedCrossRefGoogle Scholar
  5. 5.
    Bramesfeld A, Grobe T, Schwartz FW. Who is treated, and how, for depression? An analysis of statutory health insurance data in Germany. Soc Psychiatry Psychiatr Epidemiol 2007; 42(9): 740–6PubMedCrossRefGoogle Scholar
  6. 6.
    Bird CE, Rieker PP. Gender matters: an integrated model for understanding men’s and women’s health. Soc Sci Med 1999; 48(6): 745–55PubMedCrossRefGoogle Scholar
  7. 7.
    Correa-De-Araujo R. Serious gaps: how the lack of sex/gender-based research impairs health. J Womens Health (Larchmt) 2006; 15(10): 1116–22CrossRefGoogle Scholar
  8. 8.
    Le Couteur DG, Hilmer SN, Glasgow N, et al. Prescribing in older people. Aust Fam Physician 2004; 33(10): 777–81PubMedGoogle Scholar
  9. 9.
    Hamberg K. Gender bias in medicine. Womens Health (Lond Engl) 2008; 4(3): 237–43CrossRefGoogle Scholar
  10. 10.
    Norris CM, Ghali WA, Galbraith PD, et al. Women with coronary artery disease report worse health-related quality of life outcomes compared to men. Health Qual Life Outcomes 2004; 2: 21PubMedCrossRefGoogle Scholar
  11. 11.
    Anderson GD. Sex and racial differences in pharmacological response: where is the evidence? Pharmacogenetics, pharmacokinetics, and pharmacodynamics. J Womens Health (Larchmt) 2005; 14(1): 19–29CrossRefGoogle Scholar
  12. 12.
    Franconi F, Brunelleschi S, Steardo L, et al. Gender differences in drug responses. Pharmacol Res 2007; 55(2): 81–95PubMedCrossRefGoogle Scholar
  13. 13.
    Courtenay WH. Constructions of masculinity and their influence on men’s well-being: a theory of gender and health. Soc Sci Med 2000; 50(10): 1385–401PubMedCrossRefGoogle Scholar
  14. 14.
    Klarin I, Fastbom J, Wimo A. A population-based study of drug use in the very old living in a rural district of Sweden, with focus on cardiovascular drug consumption: comparison with an urban cohort. Pharmacoepidemiol Drug Saf 2003; 12(8): 669–78PubMedCrossRefGoogle Scholar
  15. 15.
    Noble RE. Drug therapy in the elderly. Metabolism 2003; 52 (10 Suppl. 2): 27–30PubMedCrossRefGoogle Scholar
  16. 16.
    Hunter KF, Cyr D. Pharmacotherapeutics in older adults. J Wound Ostomy Continence Nurs 2006; 33(6): 630–6; quiz 37–8PubMedCrossRefGoogle Scholar
  17. 17.
    McLachlan A, Hilmer S, Le Couteur D. Variability in response to medicines in older people: phenotypic and genotypic factors. Clin Pharmacol Ther 2009; 85(4): 431–3PubMedCrossRefGoogle Scholar
  18. 18.
    Klarin I, Wimo A, Fastbom J. The association of inappropriate drug use with hospitalisation and mortality: a population-based study of the very old. Drugs Aging 2005; 22(1): 69–82PubMedCrossRefGoogle Scholar
  19. 19.
    Fryckstedt J, Asker-Hagelberg C. Drug-related problems common in the emergency department of internal medicine: the cause of admission in almost every third patient according to quality follow-up. Lakartidningen 2008; 105(12-13): 894–8PubMedGoogle Scholar
  20. 20.
    Odar-Cederlof I, Oskarsson P, Ohlen G, et al. Adverse drug effect as cause of hospital admission. Common drugs are the major part according to the cross-sectional study. Lakartidningen 2008; 105(12-13): 890–3PubMedGoogle Scholar
  21. 21.
    Cumming RG, Le Couteur DG. Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 2003; 17(11): 825–37PubMedCrossRefGoogle Scholar
  22. 22.
    Passarelli MC, Jacob-Filho W, Figueras A. Adverse drug reactions in an elderly hospitalised population: inappropriate prescription is a leading cause. Drugs Aging 2005; 22(9): 767–77PubMedCrossRefGoogle Scholar
  23. 23.
    Wills P, Claesson CB, Fratiglioni L, et al. Drug use by demented and non-demented elderly people. Age Ageing 1997; 26(5): 383–91PubMedCrossRefGoogle Scholar
  24. 24.
    Anthony M, Berg MJ. Biologic and molecular mechanisms for sex differences in pharmacokinetics, pharmacodynamics, and pharmacogenetics: part I. J Womens Health Gend Based Med 2002; 11(7): 601–15PubMedCrossRefGoogle Scholar
  25. 25.
    Rademaker M. Do women have more adverse drug reactions? Am J Clin Dermatol 2001; 2(6): 349–51PubMedCrossRefGoogle Scholar
  26. 26.
    Correa-de-Araujo R, Miller GE, Banthin JS, et al. Gender differences in drug use and expenditures in a privately insured population of older adults. J Womens Health (Larchmt) 2005; 14(1): 73–81CrossRefGoogle Scholar
  27. 27.
    Pinquart M, Sorensen S. Gender differences in self-concept and psychological well-being in old age: a meta-analysis. J Gerontol B Psychol Sci Soc Sci 2001; 56(4): P195–213PubMedCrossRefGoogle Scholar
  28. 28.
    Liang J, Bennett JM, Sugisawa H, et al. Gender differences in old age mortality: roles of health behavior and baseline health status. J Clin Epidemiol 2003; 56(6): 572–82PubMedCrossRefGoogle Scholar
  29. 29.
    Rieker PP, Bird CE. Rethinking gender differences in health: why we need to integrate social and biological perspectives. J Gerontol B Psychol Sci Soc Sci 2005; 60 Spec. No. 2: 40–7PubMedCrossRefGoogle Scholar
  30. 30.
    Hall-Lipsy EA, Chisholm-Burns MA. Pharmacotherapeutic disparities: racial, ethnic, and sex variations in medication treatment. Am J Health Syst Pharm 2010; 67(6): 462–8PubMedCrossRefGoogle Scholar
  31. 31.
    SCB. Regional statistics. Stockholm: Statistiska centralbyrån (Statistics Sweden), 2006 [online]. Available from URL: http://www.ssd.scb.se/databaser/makro/start.asp?lang=2 [Accessed 2011 Jul 6]Google Scholar
  32. 32.
    Guigoz Y, Vellas B. The Mini Nutritional Assessment (MNA) for grading the nutritional state of elderly patients: presentation of the MNA, history and validation. Nestle Nutr Workshop Ser Clin Perform Programme 1999; 1: 3–11; discussion 11–2PubMedCrossRefGoogle Scholar
  33. 33.
    Folstein MF, Folstein SE, McHugh PR. “Mini-mental state”: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975; 12(3): 189–98PubMedCrossRefGoogle Scholar
  34. 34.
    Collin C, Wade DT, Davies S, et al. The Barthel ADL Index: a reliability study. Int Disabil Stud 1988; 10(2): 61–3PubMedCrossRefGoogle Scholar
  35. 35.
    Almeida OP, Almeida SA. Short versions of the geriatric depression scale: a study of their validity for the diagnosis of a major depressive episode according to ICD-10 and DSM-IV. Int J Geriatr Psychiatry 1999; 14(10): 858–65PubMedCrossRefGoogle Scholar
  36. 36.
    Lawton MP. The Philadelphia Geriatric Center Morale Scale: a revision. J Gerontol 1975; 30(1): 85–9PubMedCrossRefGoogle Scholar
  37. 37.
    American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994Google Scholar
  38. 38.
    Johnell K, Fastbom J, Rosen M, et al. Inappropriate drug use in the elderly: a nationwide register-based study. Ann Pharmacother 2007; 41(7): 1243–8PubMedCrossRefGoogle Scholar
  39. 39.
    Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. Blood Press 2009; 18(6): 308–47PubMedCrossRefGoogle Scholar
  40. 40.
    Stromberg A, Martensson J. Gender differences in patients with heart failure. Eur J Cardiovasc Nurs 2003; 2(1): 7–18PubMedCrossRefGoogle Scholar
  41. 41.
    Läkemedelsboken. Stockholm: Apoteket, 2009Google Scholar
  42. 42.
    Franklin SS, Gustin 4th W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure: the Framingham Heart Study. Circulation 1997; 96(1): 308–15PubMedCrossRefGoogle Scholar
  43. 43.
    Basu R, Franzini L, Krueger PM, et al. Gender disparities in medical expenditures attributable to hypertension in the United States. Womens Health Issues 2010; 20(2): 114–25PubMedCrossRefGoogle Scholar
  44. 44.
    Lloyd-Jones DM, Evans JC, Levy D. Hypertension in adults across the age spectrum: current outcomes and control in the community. JAMA 2005; 294(4): 466–72PubMedCrossRefGoogle Scholar
  45. 45.
    Viigimaa M, Doumas M, Vlachopoulos C, et al. Hypertension and sexual dysfunction: time to act. J Hypertens 2011; 29(2): 403–7PubMedCrossRefGoogle Scholar
  46. 46.
    Passare G, Viitanen M, Torring O, et al. Sodium and potassium disturbances in the elderly: prevalence and association with drug use. Clin Drug Investig 2004; 24(9): 535–44PubMedCrossRefGoogle Scholar
  47. 47.
    Skoog I, Lernfelt B, Landahl S, et al. 15-year longitudinal study of blood pressure and dementia. Lancet 1996; 347(9009): 1141–5PubMedCrossRefGoogle Scholar
  48. 48.
    Molander L, Gustafson Y, Lövheim H. Low blood pressure is associated with cognitive impairment in very old people. Dement Geriatr Cogn Disord 2010; 29(4): 335–41PubMedCrossRefGoogle Scholar
  49. 49.
    Verghese J, Lipton RB, Hall CB, et al. Low blood pressure and the risk of dementia in very old individuals. Neurology 2003; 61(12): 1667–72PubMedCrossRefGoogle Scholar
  50. 50.
    Molander L, Lövheim H, Norman T, et al. Lower systolic blood pressure is associated with greater mortality in people aged 85 and older. J Am Geriatr Soc 2008; 56(10): 1853–9PubMedCrossRefGoogle Scholar
  51. 51.
    Banegas JR, Segura J, de la Sierra A, et al. Gender differences in office and ambulatory control of hypertension. Am J Med 2008; 121(12): 1078–84PubMedCrossRefGoogle Scholar
  52. 52.
    Klarin I, Fastbom J, Wimo A. The use of angiotensin-converting enzyme inhibitors and other drugs with cardiovascular effects by non-demented and demented elderly with a clinical diagnosis of heart failure: a population-based study of the very old. Eur J Clin Pharmacol 2006; 62(7): 555–62PubMedCrossRefGoogle Scholar
  53. 53.
    Williams D, Bennett K, Feely J. Evidence for an age and gender bias in the secondary prevention of ischaemic heart disease in primary care. Br J Clin Pharmacol 2003; 55(6): 604–8PubMedCrossRefGoogle Scholar
  54. 54.
    Cross SE, Madson L. Models of the self: self-construals and gender. Psychol Bull 1997; 122(1): 5–37PubMedCrossRefGoogle Scholar
  55. 55.
    Cannon PJ, Connell PA, Stockley IH, et al. Prevalence of angina as assessed by a survey of prescriptions for nitrates. Lancet 1988; 1(8592): 979–81PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2011

Authors and Affiliations

  • Jon Brännström
    • 1
    Email author
  • Katarina Hamberg
    • 2
  • Lena Molander
    • 1
  • Hugo Lövheim
    • 1
  • Yngve Gustafson
    • 1
  1. 1.Department of Community Medicine and Rehabilitation, Geriatric MedicineUmeå UniversityUmeåSweden
  2. 2.Department of Public Health and Clinical Medicine, Family MedicineUmeå UniversityUmeåSweden

Personalised recommendations